Mint Tower Capital Management’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-335,000
Closed -$1.9M 283
2025
Q3
$1.9M Buy
+335,000
New +$1.72M 0.22% 72

Mint Tower Capital Management's SCPH Position: Q4 2025 in Review

Mint Tower Capital Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 335,000 shares — an estimated $1.9M sold.

Mint Tower Capital Management first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $1.9M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Mint Tower Capital Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Mint Tower Capital Management sold 335,000 scPharmaceuticals shares in Q4 2025, an estimated $1.9M.
  • Mint Tower Capital Management first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Mint Tower Capital Management's scPharmaceuticals position peaked at $1.9M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Mint Tower Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.